Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Issie Kirby is an analyst at Redburn Atlantic. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/03/2025 | DXCM | Buy Now | DexCom | $73.60 | 56.25% | Issie Kirby25% | $85 → $115 | Upgrade | Neutral → Buy | Get Alert |
| 10/10/2024 | ALC | Buy Now | Alcon | $92.92 | — | Issie Kirby25% | — | Upgrade | Sell → Neutral | Get Alert |
| 05/30/2024 | DXCM | Buy Now | DexCom | $73.60 | 76.63% | Issie Kirby25% | → $130 | Initiates | → Neutral | Get Alert |
| 05/30/2024 | TNDM | Buy Now | Tandem Diabetes Care | $20.22 | 196.74% | Issie Kirby25% | → $60 | Initiates | → Buy | Get Alert |
| 05/30/2024 | PODD | Buy Now | Insulet | $272.71 | -13.83% | Issie Kirby25% | → $235 | Initiates | → Buy | Get Alert |
| 03/19/2024 | COO | Buy Now | Cooper Companies | $83.53 | 49.65% | Issie Kirby25% | → $125 | Upgrade | Neutral → Buy | Get Alert |
| 10/05/2023 | COO | Buy Now | Cooper Companies | $83.53 | 310.63% | Issie Kirby25% | $97.5 → $85.75 | Downgrade | Buy → Neutral | Get Alert |
